The most innovative aspect of our Pilot Project is to use EMR data to define NSAID usage and CVD outcomes. We will use EMR data to define a large cohort of RA and OA patients. We will create an ondemand registry to target biospecimen collection using discarded tissue from routine care. We have already demonstrated that such an approach is feasible for patients with RA (see Preliminary Data in the Approach Section). We have not yet demonstrated that we can define NSAID usage and CVD outcome with high sensitivity and specificity. If we are indeed able to define precisely NSAID usage and CVD outcome, then we will be in a position to conduct large, well-powered genomic studies later in the funding period.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54HL117798-01
Application #
8126776
Study Section
Special Emphasis Panel (ZGM1-PPBC-0 (GL))
Project Start
2012-08-01
Project End
2017-05-31
Budget Start
2012-08-01
Budget End
2013-05-31
Support Year
1
Fiscal Year
2012
Total Cost
$311,358
Indirect Cost
$70,306
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Martin, Sarah A; Gijón, Miguel A; Voelker, Dennis R et al. (2014) Measurement of lysophospholipid acyltransferase activities using substrate competition. J Lipid Res 55:782-91
Keramati, Ali R; Fathzadeh, Mohsen; Go, Gwang-Woong et al. (2014) A form of the metabolic syndrome associated with mutations in DYRK1B. N Engl J Med 370:1909-19
Chakraborty, Raja; Bhullar, Rajinder P; Dakshinamurti, Shyamala et al. (2014) Inverse agonism of SQ 29,548 and Ramatroban on Thromboxane A2 receptor. PLoS One 9:e85937
Zarini, Simona; Hankin, Joseph A; Murphy, Robert C et al. (2014) Lysophospholipid acyltransferases and eicosanoid biosynthesis in zebrafish myeloid cells. Prostaglandins Other Lipid Mediat 113-115:52-61
Obinata, Hideru; Gutkind, Sarah; Stitham, Jeremiah et al. (2014) Individual variation of human S1P? coding sequence leads to heterogeneity in receptor function and drug interactions. J Lipid Res 55:2665-75
Toung, Jonathan M; Lahens, Nicholas; Hogenesch, John B et al. (2014) Detection theory in identification of RNA-DNA sequence differences using RNA-sequencing. PLoS One 9:e112040
Jiang, Yan; Djuric, Zora; Sen, Ananda et al. (2014) Biomarkers for personalizing omega-3 fatty acid dosing. Cancer Prev Res (Phila) 7:1011-22
Tang, Wai Ho; Stitham, Jeremiah; Jin, Yu et al. (2014) Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation 129:1598-609
Lu, Yi-Chien; Chang, Sung-Hee; Hafner, Markus et al. (2014) ELAVL1 modulates transcriptome-wide miRNA binding in murine macrophages. Cell Rep 9:2330-43
O'Donnell, Valerie B; Murphy, Robert C; Watson, Steve P (2014) Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets. Circ Res 114:1185-203

Showing the most recent 10 out of 19 publications